Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00006267
What this trial is testing

Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00002600
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364
What this trial is testing

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Low Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more
NRG Oncology 450
Testing effectiveness (Phase 2)Study completedNCT01381861
What this trial is testing

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Tracon Pharmaceuticals Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00928642
What this trial is testing

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01105650
What this trial is testing

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Ended earlyNCT01821859
What this trial is testing

Abraxane/Bevacizumab

Who this might be right for
Ovarian CancerPeritoneal Cancer
OHSU Knight Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00880360
What this trial is testing

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 19
Early research (Phase 1)WithdrawnNCT02470559
What this trial is testing

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Who this might be right for
Malignant Ovarian Clear Cell TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+14 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00721162
What this trial is testing

Study of Ramucirumab in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Looking for participantsNCT05983276
What this trial is testing

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University 40
Not applicableStudy completedNCT05256576
What this trial is testing

KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer

Who this might be right for
Ovary CancerFallopian Tube CancerPeritoneum Cancer+1 more
Charite University, Berlin, Germany 465
Large-scale testing (Phase 3)Study completedNCT00002717
What this trial is testing

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 324
Testing effectiveness (Phase 2)Ended earlyNCT00505661
What this trial is testing

Letrozole in Patients With Ovarian Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT05129969
What this trial is testing

Registry Platform Ovarian and Endometrial Cancer

Who this might be right for
Ovarian CancerEndometrial CancerOvary Neoplasm+4 more
iOMEDICO AG 1,975
Large-scale testing (Phase 3)Active Not RecruitingNCT02502266
What this trial is testing

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+12 more
National Cancer Institute (NCI) 582
Early research (Phase 1)Study completedNCT00562003
What this trial is testing

Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
University of Alabama at Birmingham 26
Testing effectiveness (Phase 2)Study completedNCT00510653
What this trial is testing

Gleevec Study for Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 73
Early research (Phase 1)Not Yet RecruitingNCT06846424
What this trial is testing

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaPeritoneal Carcinoma
Shanghai Gynecologic Oncology Group 24
Next Page